S Chand Publishes Good News: Interim Dividend of ₹4 Per Share

Unknown Apr 02, 2026 1,250 Views

S Chand & Company Limited has declared interim dividend ₹4 per equity share after obtaining approval for its audited financial results for the year and quarter ended March 31, 2025. This decision reinforces the company's sustained efforts towards rewarding shareholders and its strong fina...

Interim Dividend Announcement

The Board of Directors announced an interim dividend of ₹4 per share at its meeting on May 23, 2025.
This comes after the company's consistent payment of dividends in past years, with the latest being ₹3 per share in September 2024.

Board Meeting and Financial Results

The interim dividend was approved along with the audited standalone and consolidated financial results for the quarter and year ended March 31, 2025.
The agenda for the board meeting involved going through financial performance and other business issues, reflecting a thorough analysis of the operations of the company.

Dividend History

S Chand & Company boasts a consistent dividend history with declared dividends of ₹3 per share in both 2024 and 2023.
The interim dividend currently declared is an escalation from the earlier payouts, reflecting enhanced profitability or a strategic move to increase shareholder value.

Shareholder Impact and Market Performance

At the current share price of about ₹232.87, the dividend yield is a significant motivator for the investor.
The stock of the company has demonstrated strength with a rise of 10.60% in the last month and three-year growth of more than 140%.

Background and Context

S Chand & Company Ltd, one of the best players in India's publishing industry, continues to prove its financial strength by making routine dividend announcements and stable market performance. The recent interim dividend declaration is likely to further strengthen investor optimism and indicates the company's optimistic outlook for the quarters ahead.

Sources: INDmoney, ET Money, Business Standard, Economic Times

Stay Ahead – Explore Now! SBI Commits $1 Billion to Finance Sun Pharma’s Organon Deal